精细地图和原发性硬化胆管炎遗传风险位置的分子特征
Elizabeth C Goode1,2,3, Laura Fachal1, Nikolaos Panousis1
1Wellcome Sanger Institute, Hinxton, Cambridge, UK.
Nature communications
|November 6, 2024
概括
这项研究通过分析T细胞基因表达,确定了原发性硬化性脑膜炎 (PSC) 背后的基因和调控机制. 研究结果提名了这种复杂的自身免疫性肝病的潜在药物点.
科学领域:
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 初级硬化性胆道炎 (PSC) 是一种具有强烈遗传成分的慢性肝病.
- 全基因组关联研究 (GWAS) 已经确定了23个PSC易感位置,主要是在非编码区域.
- 了解这些基因位点对附近基因的调节作用对于PSC生物学至关重要.
研究的目的:
- 为了识别由PSC易感位点调节的基因.
- 提高对PSC病变发生的生物学理解.
- 为PSC提名潜在的治疗点.
主要方法:
- 使用PSC和性结肠炎患者的六个T细胞子集构建一个eQTL (表达量性特征位点) 地图.
- 在PSC GWAS loci和eQTLs之间进行局部化分析.
- 贝叶斯精细映射用于确定因果变异和识别效应基因.
主要成果:
- 确定了10,459个独特的eGenes,其中87%是PSC相关的T细胞类型共享的.
- 在五个非编码和一个编码的PSC位点进行了局部化分析,涉及到特定基因 (UBASH3A,PRKD2,ETS2,AP003774.1/CCDC88B,SH2B3).
- 精细映射确定了三分之一的PSC位点的可能因果变异,其中包括两种单变异分辨率.
结论:
- 这项研究通过T细胞eQTL映射将PSC GWAS位点与特定的基因和生物机制联系起来.
- 已识别的效应基因和因果变异为PSC病变产生提供了洞察力.
- 被提名的基因和机制为未来的PSC疗法提供了潜在的点.
更多相关视频
09:52Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
24.3K
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
12.2K
相关概念视频
Genome-wide Association Studies-GWAS
12.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.5K
Single Nucleotide Polymorphisms-SNPs
14.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.1K
